Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

The Role of Indigestible Oligosaccharides in Alleviating Human Chronic Diseases by Regulating Gut Microbiota: A Review

Version 1 : Received: 30 May 2024 / Approved: 31 May 2024 / Online: 3 June 2024 (08:02:01 CEST)

A peer-reviewed article of this Preprint also exists.

Yuan, M.; Zhang, Z.; Liu, T.; Feng, H.; Liu, Y.; Chen, K. The Role of Nondigestible Oligosaccharides in Alleviating Human Chronic Diseases by Regulating the Gut Microbiota: A Review. Foods 2024, 13, 2157. Yuan, M.; Zhang, Z.; Liu, T.; Feng, H.; Liu, Y.; Chen, K. The Role of Nondigestible Oligosaccharides in Alleviating Human Chronic Diseases by Regulating the Gut Microbiota: A Review. Foods 2024, 13, 2157.

Abstract

The gut has been a focus of chronic disease research. The gut microbiota produces metabolites that act as signaling molecules and substrates, closely influencing host health. Indigestible oli-gosaccharides (NDOs), as a common dietary fiber, play an important role in regulating the structure and function of gut microbiota. Their mechanism of action is mainly attributed to their carbon source as specific probiotics, producing related metabolites, and regulating the gut mi-crobial community. However, due to the selective utilization of oligosaccharides, some factors such as the types and structures of oligosaccharides have different impacts on the composition of microbial populations and the production of metabolites in the colon ecosystem. This review systematically describes the key factors influencing the selective utilization of oligosaccharides in microorganisms and elaborates how oligosaccharides affect the host's immune system, inflam-mation levels and energy metabolism by regulating microbial diversity and metabolic function, which in turn will affect the onset and progress of chronic diseases, especially diabetes, obesity, depression and intestinal inflammatory diseases, constipation. In this review, we re-examine the interaction mechanisms between gut microbiota and its associated metabolites and diseases, and explore new strategies for promoting human health and combating chronic diseases through di-etary interventions.

Keywords

nondigestible oligosaccharides; gut microbiota; short-chain fatty acids; constipation; diabetes; obesity; depression; inflammatory bowel disease

Subject

Public Health and Healthcare, Primary Health Care

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.